These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15583694)

  • 21. Isoliquiritigenin (ISL) inhibits ErbB3 signaling in prostate cancer cells.
    Jung JI; Chung E; Seon MR; Shin HK; Kim EJ; Lim SS; Chung WY; Park KK; Park JH
    Biofactors; 2006; 28(3-4):159-68. PubMed ID: 17473376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heregulin-ErbB3-Driven Tumor Growth Persists in PI3 Kinase Mutant Cancer Cells.
    Yarar D; Lahdenranta J; Kubasek W; Nielsen UB; MacBeath G
    Mol Cancer Ther; 2015 Sep; 14(9):2072-80. PubMed ID: 26116360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
    Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R
    Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulator of G-protein signaling 2 (RGS2) inhibits androgen-independent activation of androgen receptor in prostate cancer cells.
    Cao X; Qin J; Xie Y; Khan O; Dowd F; Scofield M; Lin MF; Tu Y
    Oncogene; 2006 Jun; 25(26):3719-34. PubMed ID: 16449965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ErbB family and androgen receptor signaling are targets of Celecoxib in prostate cancer.
    Brizzolara A; Benelli R; Venè R; Barboro P; Poggi A; Tosetti F; Ferrari N
    Cancer Lett; 2017 Aug; 400():9-17. PubMed ID: 28450158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.
    Xie Y; Wolff DW; Lin MF; Tu Y
    Mol Pharmacol; 2007 Jul; 72(1):73-85. PubMed ID: 17430995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation.
    Chen SY; Cai C; Fisher CJ; Zheng Z; Omwancha J; Hsieh CL; Shemshedini L
    Oncogene; 2006 Nov; 25(54):7212-23. PubMed ID: 16732317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ErbB3-binding protein EBP1 decreases ErbB2 levels via a transcriptional mechanism.
    Ghosh A; Awasthi S; Hamburger AW
    Oncol Rep; 2013 Mar; 29(3):1161-6. PubMed ID: 23242156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation.
    Mahajan NP; Liu Y; Majumder S; Warren MR; Parker CE; Mohler JL; Earp HS; Whang YE
    Proc Natl Acad Sci U S A; 2007 May; 104(20):8438-43. PubMed ID: 17494760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
    Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
    J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The CXCL12/CXCR4 axis promotes ligand-independent activation of the androgen receptor.
    Kasina S; Macoska JA
    Mol Cell Endocrinol; 2012 Apr; 351(2):249-63. PubMed ID: 22245379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases.
    Liu Y; Karaca M; Zhang Z; Gioeli D; Earp HS; Whang YE
    Oncogene; 2010 Jun; 29(22):3208-16. PubMed ID: 20383201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A designed cell-permeable aptamer-based corepressor peptide is highly specific for the androgen receptor and inhibits prostate cancer cell growth in a vector-free mode.
    Reeb CA; Gerlach C; Heinssmann M; Prade I; Ceraline J; Roediger J; Roell D; Baniahmad A
    Endocrinology; 2011 Jun; 152(6):2174-83. PubMed ID: 21486935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
    Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of androgen receptor transactivation by FoxH1. A newly identified androgen receptor corepressor.
    Chen G; Nomura M; Morinaga H; Matsubara E; Okabe T; Goto K; Yanase T; Zheng H; Lu J; Nawata H
    J Biol Chem; 2005 Oct; 280(43):36355-63. PubMed ID: 16120611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydrogen sulfide represses androgen receptor transactivation by targeting at the second zinc finger module.
    Zhao K; Li S; Wu L; Lai C; Yang G
    J Biol Chem; 2014 Jul; 289(30):20824-35. PubMed ID: 24942741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells.
    Lin HK; Altuwaijri S; Lin WJ; Kan PY; Collins LL; Chang C
    J Biol Chem; 2002 Sep; 277(39):36570-6. PubMed ID: 12119296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the androgen receptor in human prostate cancer cells.
    Yuan H; Gong A; Young CY
    Carcinogenesis; 2005 Apr; 26(4):793-801. PubMed ID: 15661808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A natural androgen receptor antagonist induces cellular senescence in prostate cancer cells.
    Hessenkemper W; Roediger J; Bartsch S; Houtsmuller AB; van Royen ME; Petersen I; Grimm MO; Baniahmad A
    Mol Endocrinol; 2014 Nov; 28(11):1831-40. PubMed ID: 25203674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ectopic expression of the ErbB-3 binding protein ebp1 inhibits growth and induces differentiation of human breast cancer cell lines.
    Lessor TJ; Yoo JY; Xia X; Woodford N; Hamburger AW
    J Cell Physiol; 2000 Jun; 183(3):321-9. PubMed ID: 10797306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.